Hospital begins monoclonal antibody treatment
Updated:
Updated:
Drug is said to bring down hospitalisation by 70%
Share Article
Drug is said to bring down hospitalisation by 70%
Kauvery Hospital in Chennai has treated a mildly symptomatic but high-risk COVID-19 patient with the monoclonal antibody cocktail that has been approved for emergency use in India. A statement issued by the hospital claimed that this was the first time the treatment had been used by a hospital in Tamil Nadu.
The individual was a cancer patient, who was recently diagnosed with early onset of renal failure, and hence was at higher risk of developing severe complications due to COVID-19.
Mixed monoclonal antibody treatment (Casirivimab and Imdevimab) is now available in India. The treatment gained popularity after then-US President Donald Trump was.
Mehul Choksi flees to Cuba fearing extradition; Roche’s Antibody Cocktail to treat COVID now available in India; Biden Welcomes call for sanctions on Belarus.
Loading the player.
COVID vaccination key to curbing pandemic but govt doesn t seem to care: Rahul Gandhi
Asserting that the number of daily inoculations in the country has come down, Congress leader Rahul Gandhi on Monday said vaccination is the key to controlling the pandemic but the government does not seem to care. He shared a graph showing the decline in the number of vaccine doses administered during April and May (till 20th) and pointed out that the average number of vaccination per day has fallen below the daily production.
Kia Motors rebrands itself as Kia India
South Korean automaker Kia on Monday said it has officially changed its name in the country to Kia India from Kia Motors earlier. The change of name is part of the company s new brand identity which symbolises it becoming an enterprise that invests in and produces more than just vehicles to offer a long range of sustainable mobility solutions, it said.